Minimally modified low density lipoprotein is biologically active in vivo in mice.
Open Access
- 1 June 1991
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 87 (6), 2253-2257
- https://doi.org/10.1172/jci115261
Abstract
Minimally modified low density lipoprotein (MM-LDL), derived by mild iron oxidation or prolonged storage at 4 degrees C, has been shown to induce certain inflammatory responses in vascular cells in tissue culture. These include induction of monocyte (but not neutrophil) adherence to endothelial cells (EC), induction of EC production of colony stimulating factors (CSF), and induction of EC and smooth muscle cell production of monocyte chemotactic protein (MCP-1). To test for biologic activity in vivo, microgram quantities of MM-LDL were injected into mice, sera were assayed for CSF activity, and tissues were subjected to Northern analysis. After injection of MM-LDL, CSF activity increased approximately 7-26-fold but remained near control levels after injection of native LDL. Essentially all of the induced CSF activity was due to macrophage CSF as judged by antibody inhibition. Injection of MM-LDL into a mouse strain (C3H/HeJ) that is resistant to bacterial LPS gave similar results, indicating that the induction of CSF was not due to contaminating LPS and suggesting that there are differences in the pathways by which LPS and MM-LDL trigger cytokine production. In addition, after injection of MM-LDL, mRNA for JE, the mouse homologue of MCP-1, was markedly induced in various tissues, but was not induced after injection of native LDL. We conclude, therefore, that MM-LDL is biologically active in vivo and may contribute to the early stages of atherosclerosis by acting as an inflammatory agent.Keywords
This publication has 33 references indexed in Scilit:
- Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells.Proceedings of the National Academy of Sciences of the United States of America, 1990
- Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1984
- Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1984
- Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.Proceedings of the National Academy of Sciences of the United States of America, 1984
- The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions.1981
- Purification and characterization of a human T-lymphocyte-derived granulocyte-macrophage colony-stimulating factor.1981
- Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophagesProceedings of the National Academy of Sciences of the United States of America, 1980
- Dietary induced atherogenesis in swine. Morphology of the intima in prelesion stages.1979
- LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in cultureAtherosclerosis, 1979
- Transforming viruses directly reduce the cellular growth requirement for a platelet derived growth factorJournal of Cellular Physiology, 1978